With AC/DC announcing that they’re getting back together for a new studio album, frontman Brian Johnson explained how an experimental treatment helped him deal with hearing loss and get his singing ...

Tau Morphomer™ is the focus of a partnership with Eli Lilly and Company LAUSANNE, Switzerland, July 17, 2019 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage ...

The use of electric fields in combination with small doses of antibiotics for enhanced treatment of biofilms is termed the ‘bioelectric effect’ (BE). Different mechanisms of action for the AC and DC ...

USMNT star Christian Pulisic was injured in the match against Australia, and AC Milan is frustrated with Mauricio ...

In 2020 Oregon voters approved Measure 110, the nation’s first law decriminalizing possession of small amounts of drugs, including fentanyl, heroin and methamphetamines. Under Measure 110, people ...

Phase 2 primary endpoint of PASI-75 and key secondary endpoints met in all of the three dosing groups at Week 12 AC-201 was generally well tolerated at all dose levels with no SAEs or AEs leading to ...

Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer Patients with early-stage resected ...

AC Immune SA’s stock ACIU soared 13% premarket Tuesday, after the Swiss-based biotech said it has received U.S. Food and Drug Administration fast-track designation for an Alzheimer’s disease treatment ...

Successful conduct of phase III clinical trials can be challenging, particularly in the adjuvant breast cancer setting, where relatively good-prognosis disease can result in low outcome event rates, ...